Status: retired, Primitive. Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3693993011 | Tacalcitol (as tacalcitol monohydrate) 4 microgram/g cutaneous ointment | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3693994017 | Product containing precisely tacalcitol (as tacalcitol monohydrate) 4 microgram/1 gram conventional release cutaneous ointment (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tacalcitol (as tacalcitol monohydrate) 4 microgram/g cutaneous ointment | Is a | Tacalcitol only product in cutaneous dose form | false | Inferred relationship | Some | ||
| Tacalcitol (as tacalcitol monohydrate) 4 microgram/g cutaneous ointment | Is a | Tacalcitol-containing product | false | Inferred relationship | Some | ||
| Tacalcitol (as tacalcitol monohydrate) 4 microgram/g cutaneous ointment | Has active ingredient | Skin agent | false | Inferred relationship | Some | ||
| Tacalcitol (as tacalcitol monohydrate) 4 microgram/g cutaneous ointment | Has active ingredient | Tacalcitol | false | Inferred relationship | Some | ||
| Tacalcitol (as tacalcitol monohydrate) 4 microgram/g cutaneous ointment | Is a | Topical dermatological preparation | false | Inferred relationship | Some | ||
| Tacalcitol (as tacalcitol monohydrate) 4 microgram/g cutaneous ointment | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Some | ||
| Tacalcitol (as tacalcitol monohydrate) 4 microgram/g cutaneous ointment | Has manufactured dose form | Cutaneous ointment | false | Inferred relationship | Some | ||
| Tacalcitol (as tacalcitol monohydrate) 4 microgram/g cutaneous ointment | Is a | Product manufactured as topical dosage form | false | Inferred relationship | Some | ||
| Tacalcitol (as tacalcitol monohydrate) 4 microgram/g cutaneous ointment | Is a | Product manufactured as cutaneous dose form | false | Inferred relationship | Some | ||
| Tacalcitol (as tacalcitol monohydrate) 4 microgram/g cutaneous ointment | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Tacalcitol (as tacalcitol monohydrate) 4 microgram/g cutaneous ointment | Has concentration strength numerator value | 4 | false | Inferred relationship | Some | 1 | |
| Tacalcitol (as tacalcitol monohydrate) 4 microgram/g cutaneous ointment | Has concentration strength denominator unit | g | false | Inferred relationship | Some | 1 | |
| Tacalcitol (as tacalcitol monohydrate) 4 microgram/g cutaneous ointment | Has precise active ingredient | Tacalcitol monohydrate | false | Inferred relationship | Some | 1 | |
| Tacalcitol (as tacalcitol monohydrate) 4 microgram/g cutaneous ointment | Has concentration strength numerator unit | mcg | false | Inferred relationship | Some | 1 | |
| Tacalcitol (as tacalcitol monohydrate) 4 microgram/g cutaneous ointment | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Tacalcitol (as tacalcitol monohydrate) 4 microgram/g cutaneous ointment | Has BoSS | Tacalcitol | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set
FHIR